After 20 years of support, Linda Rubenstein, a Gaucher patient, says the chief executive knows her. “He made it his business to know,’’ she said.
(Dina Rudick/Globe Staff)
Genzyme talks trigger patient jitters
Drug firm nurtured bonds with customers, but what if it is sold?
After 20 years of support, Linda Rubenstein, a Gaucher patient, says the chief executive knows her. “He made it his business to know,’’ she said.
(Dina Rudick/Globe Staff)
Linda Rubenstein puttered around her kitchen, pink earrings flashing as she talked about her social life, her business, her teenage son. (Full article: 965 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
